Global IPV Vaccine Market Growth 2025-2031

February 2025 | 83 pages | ID: G58B981D77E9EN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global IPV Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for IPV Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for IPV Vaccine by Country/Region, 2020, 2024 & 2031
2.2 IPV Vaccine Segment by Type
  2.2.1 Mahoney
  2.2.2 MEF1
  2.2.3 Saukett
2.3 IPV Vaccine Sales by Type
  2.3.1 Global IPV Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global IPV Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global IPV Vaccine Sale Price by Type (2020-2025)
2.4 IPV Vaccine Segment by Application
  2.4.1 Private Distribution Channel
  2.4.2 Public Distribution Channel
2.5 IPV Vaccine Sales by Application
  2.5.1 Global IPV Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global IPV Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global IPV Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global IPV Vaccine Breakdown Data by Company
  3.1.1 Global IPV Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global IPV Vaccine Sales Market Share by Company (2020-2025)
3.2 Global IPV Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global IPV Vaccine Revenue by Company (2020-2025)
  3.2.2 Global IPV Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global IPV Vaccine Sale Price by Company
3.4 Key Manufacturers IPV Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers IPV Vaccine Product Location Distribution
  3.4.2 Players IPV Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IPV VACCINE BY GEOGRAPHIC REGION

4.1 World Historic IPV Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global IPV Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global IPV Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic IPV Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global IPV Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global IPV Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas IPV Vaccine Sales Growth
4.4 APAC IPV Vaccine Sales Growth
4.5 Europe IPV Vaccine Sales Growth
4.6 Middle East & Africa IPV Vaccine Sales Growth

5 AMERICAS

5.1 Americas IPV Vaccine Sales by Country
  5.1.1 Americas IPV Vaccine Sales by Country (2020-2025)
  5.1.2 Americas IPV Vaccine Revenue by Country (2020-2025)
5.2 Americas IPV Vaccine Sales by Type (2020-2025)
5.3 Americas IPV Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC IPV Vaccine Sales by Region
  6.1.1 APAC IPV Vaccine Sales by Region (2020-2025)
  6.1.2 APAC IPV Vaccine Revenue by Region (2020-2025)
6.2 APAC IPV Vaccine Sales by Type (2020-2025)
6.3 APAC IPV Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe IPV Vaccine by Country
  7.1.1 Europe IPV Vaccine Sales by Country (2020-2025)
  7.1.2 Europe IPV Vaccine Revenue by Country (2020-2025)
7.2 Europe IPV Vaccine Sales by Type (2020-2025)
7.3 Europe IPV Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa IPV Vaccine by Country
  8.1.1 Middle East & Africa IPV Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa IPV Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa IPV Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa IPV Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IPV Vaccine
10.3 Manufacturing Process Analysis of IPV Vaccine
10.4 Industry Chain Structure of IPV Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 IPV Vaccine Distributors
11.3 IPV Vaccine Customer

12 WORLD FORECAST REVIEW FOR IPV VACCINE BY GEOGRAPHIC REGION

12.1 Global IPV Vaccine Market Size Forecast by Region
  12.1.1 Global IPV Vaccine Forecast by Region (2026-2031)
  12.1.2 Global IPV Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global IPV Vaccine Forecast by Type (2026-2031)
12.7 Global IPV Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline Plc
  13.1.1 GlaxoSmithKline Plc Company Information
  13.1.2 GlaxoSmithKline Plc IPV Vaccine Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GlaxoSmithKline Plc Main Business Overview
  13.1.5 GlaxoSmithKline Plc Latest Developments
13.2 Sanofi S.A
  13.2.1 Sanofi S.A Company Information
  13.2.2 Sanofi S.A IPV Vaccine Product Portfolios and Specifications
  13.2.3 Sanofi S.A IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Sanofi S.A Main Business Overview
  13.2.5 Sanofi S.A Latest Developments
13.3 Serum Institute of India Pvt. Ltd.
  13.3.1 Serum Institute of India Pvt. Ltd. Company Information
  13.3.2 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolios and Specifications
  13.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Serum Institute of India Pvt. Ltd. Main Business Overview
  13.3.5 Serum Institute of India Pvt. Ltd. Latest Developments
13.4 PT Bio Farma
  13.4.1 PT Bio Farma Company Information
  13.4.2 PT Bio Farma IPV Vaccine Product Portfolios and Specifications
  13.4.3 PT Bio Farma IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 PT Bio Farma Main Business Overview
  13.4.5 PT Bio Farma Latest Developments
13.5 AJ Vaccines
  13.5.1 AJ Vaccines Company Information
  13.5.2 AJ Vaccines IPV Vaccine Product Portfolios and Specifications
  13.5.3 AJ Vaccines IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 AJ Vaccines Main Business Overview
  13.5.5 AJ Vaccines Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. IPV Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. IPV Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mahoney
Table 4. Major Players of MEF1
Table 5. Major Players of Saukett
Table 6. Global IPV Vaccine Sales byType (2020-2025) & (Units)
Table 7. Global IPV Vaccine Sales Market Share byType (2020-2025)
Table 8. Global IPV Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global IPV Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global IPV Vaccine Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global IPV Vaccine Sale by Application (2020-2025) & (Units)
Table 12. Global IPV Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global IPV Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global IPV Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global IPV Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global IPV Vaccine Sales by Company (2020-2025) & (Units)
Table 17. Global IPV Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global IPV Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global IPV Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global IPV Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers IPV Vaccine Producing Area Distribution and Sales Area
Table 22. Players IPV Vaccine Products Offered
Table 23. IPV Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global IPV Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 27. Global IPV Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global IPV Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global IPV Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global IPV Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 31. Global IPV Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global IPV Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global IPV Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas IPV Vaccine Sales by Country (2020-2025) & (Units)
Table 35. Americas IPV Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas IPV Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas IPV Vaccine Sales byType (2020-2025) & (Units)
Table 38. Americas IPV Vaccine Sales by Application (2020-2025) & (Units)
Table 39. APAC IPV Vaccine Sales by Region (2020-2025) & (Units)
Table 40. APAC IPV Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC IPV Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC IPV Vaccine Sales byType (2020-2025) & (Units)
Table 43. APAC IPV Vaccine Sales by Application (2020-2025) & (Units)
Table 44. Europe IPV Vaccine Sales by Country (2020-2025) & (Units)
Table 45. Europe IPV Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe IPV Vaccine Sales byType (2020-2025) & (Units)
Table 47. Europe IPV Vaccine Sales by Application (2020-2025) & (Units)
Table 48. Middle East & Africa IPV Vaccine Sales by Country (2020-2025) & (Units)
Table 49. Middle East & Africa IPV Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa IPV Vaccine Sales byType (2020-2025) & (Units)
Table 51. Middle East & Africa IPV Vaccine Sales by Application (2020-2025) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of IPV Vaccine
Table 53. Key Market Challenges & Risks of IPV Vaccine
Table 54. Key IndustryTrends of IPV Vaccine
Table 55. IPV Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. IPV Vaccine Distributors List
Table 58. IPV Vaccine Customer List
Table 59. Global IPV Vaccine SalesForecast by Region (2026-2031) & (Units)
Table 60. Global IPV Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas IPV Vaccine SalesForecast by Country (2026-2031) & (Units)
Table 62. Americas IPV Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC IPV Vaccine SalesForecast by Region (2026-2031) & (Units)
Table 64. APAC IPV Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe IPV Vaccine SalesForecast by Country (2026-2031) & (Units)
Table 66. Europe IPV Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa IPV Vaccine SalesForecast by Country (2026-2031) & (Units)
Table 68. Middle East & Africa IPV Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global IPV Vaccine SalesForecast byType (2026-2031) & (Units)
Table 70. Global IPV Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global IPV Vaccine SalesForecast by Application (2026-2031) & (Units)
Table 72. Global IPV Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. GlaxoSmithKline Plc Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. GlaxoSmithKline Plc IPV Vaccine Product Portfolios and Specifications
Table 75. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. GlaxoSmithKline Plc Main Business
Table 77. GlaxoSmithKline Plc Latest Developments
Table 78. Sanofi S.A Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi S.A IPV Vaccine Product Portfolios and Specifications
Table 80. Sanofi S.A IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sanofi S.A Main Business
Table 82. Sanofi S.A Latest Developments
Table 83. Serum Institute of India Pvt. Ltd. Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolios and Specifications
Table 85. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Serum Institute of India Pvt. Ltd. Main Business
Table 87. Serum Institute of India Pvt. Ltd. Latest Developments
Table 88. PT BioFarma Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. PT BioFarma IPV Vaccine Product Portfolios and Specifications
Table 90. PT BioFarma IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. PT BioFarma Main Business
Table 92. PT BioFarma Latest Developments
Table 93. AJ Vaccines Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. AJ Vaccines IPV Vaccine Product Portfolios and Specifications
Table 95. AJ Vaccines IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. AJ Vaccines Main Business
Table 97. AJ Vaccines Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of IPV Vaccine
Figure 2. IPV Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IPV Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global IPV Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. IPV Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. IPV Vaccine Sales Market Share by Country/Region (2024)
Figure 10. IPV Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Mahoney
Figure 12. Product Picture of MEF1
Figure 13. Product Picture of Saukett
Figure 14. Global IPV Vaccine Sales Market Share byType in 2025
Figure 15. Global IPV Vaccine Revenue Market Share byType (2020-2025)
Figure 16. IPV Vaccine Consumed in Private Distribution Channel
Figure 17. Global IPV Vaccine Market: Private Distribution Channel (2020-2025) & (Units)
Figure 18. IPV Vaccine Consumed in Public Distribution Channel
Figure 19. Global IPV Vaccine Market: Public Distribution Channel (2020-2025) & (Units)
Figure 20. Global IPV Vaccine Sale Market Share by Application (2024)
Figure 21. Global IPV Vaccine Revenue Market Share by Application in 2025
Figure 22. IPV Vaccine Sales by Company in 2025 (Units)
Figure 23. Global IPV Vaccine Sales Market Share by Company in 2025
Figure 24. IPV Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global IPV Vaccine Revenue Market Share by Company in 2025
Figure 26. Global IPV Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global IPV Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas IPV Vaccine Sales 2020-2025 (Units)
Figure 29. Americas IPV Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC IPV Vaccine Sales 2020-2025 (Units)
Figure 31. APAC IPV Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe IPV Vaccine Sales 2020-2025 (Units)
Figure 33. Europe IPV Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa IPV Vaccine Sales 2020-2025 (Units)
Figure 35. Middle East & Africa IPV Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas IPV Vaccine Sales Market Share by Country in 2025
Figure 37. Americas IPV Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas IPV Vaccine Sales Market Share byType (2020-2025)
Figure 39. Americas IPV Vaccine Sales Market Share by Application (2020-2025)
Figure 40. United States IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC IPV Vaccine Sales Market Share by Region in 2025
Figure 45. APAC IPV Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC IPV Vaccine Sales Market Share byType (2020-2025)
Figure 47. APAC IPV Vaccine Sales Market Share by Application (2020-2025)
Figure 48. China IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe IPV Vaccine Sales Market Share by Country in 2025
Figure 56. Europe IPV Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe IPV Vaccine Sales Market Share byType (2020-2025)
Figure 58. Europe IPV Vaccine Sales Market Share by Application (2020-2025)
Figure 59. Germany IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60.France IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa IPV Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa IPV Vaccine Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa IPV Vaccine Sales Market Share by Application (2020-2025)
Figure 67. Egypt IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries IPV Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of IPV Vaccine in 2025
Figure 73. Manufacturing Process Analysis of IPV Vaccine
Figure 74. Industry Chain Structure of IPV Vaccine
Figure 75. Channels of Distribution
Figure 76. Global IPV Vaccine Sales MarketForecast by Region (2026-2031)
Figure 77. Global IPV Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global IPV Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 79. Global IPV Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global IPV Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global IPV Vaccine Revenue Market ShareForecast by Application (2026-2031)